Supernus Pharmaceuticals
SUPN
SUPN
250 hedge funds and large institutions have $1.93B invested in Supernus Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 67 increasing their positions, 98 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.33% less ownership
Funds ownership: 105.91% → 103.59% (-2.3%)
32% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 98
Holders
250
Holding in Top 10
2
Calls
$3.47M
Puts
$2.25M
Top Buyers
| 1 | +$38.4M | |
| 2 | +$6.04M | |
| 3 | +$5.27M | |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$5.17M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.81M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$23.7M | |
| 3 | -$5.49M | |
| 4 |
Two Sigma Investments
New York
|
-$5.1M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$4.32M |